
### [NCIT:C87797](http://purl.obolibrary.org/obo/NCIT_C87797)
**Label:** Secondary Central Nervous System Lymphoma

**Subclasses:** [NCIT:C114950](http://purl.obolibrary.org/obo/NCIT_C114950) (Secondary Central Nervous System Non-Hodgkin Lymphoma), [NCIT:C5057](http://purl.obolibrary.org/obo/NCIT_C5057) (Metastatic Hodgkin Lymphoma in the Cerebral Hemisphere), [NCIT:C114949](http://purl.obolibrary.org/obo/NCIT_C114949) (Secondary Central Nervous System Hodgkin Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 53.10%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39800](http://purl.obolibrary.org/obo/NCIT_C39800) (Sickle Cell Trait))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39799](http://purl.obolibrary.org/obo/NCIT_C39799) (Loss of Chromosome 21))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39798](http://purl.obolibrary.org/obo/NCIT_C39798) (Loss of Chromosome 2))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39795](http://purl.obolibrary.org/obo/NCIT_C39795) (Loss of Chromosome 14q))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39788](http://purl.obolibrary.org/obo/NCIT_C39788) (MET Gene Mutation))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39787](http://purl.obolibrary.org/obo/NCIT_C39787) (Multiple Tumor Masses))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39786](http://purl.obolibrary.org/obo/NCIT_C39786) (Bilateral Disease))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39783](http://purl.obolibrary.org/obo/NCIT_C39783) (Retinal Hemangioblastoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39752](http://purl.obolibrary.org/obo/NCIT_C39752) (Refractory Disease))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39751](http://purl.obolibrary.org/obo/NCIT_C39751) (Glioblastoma, IDH-Mutant))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39748](http://purl.obolibrary.org/obo/NCIT_C39748) (Lymphoblast-Like Neoplastic B-Lymphocyte))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39747](http://purl.obolibrary.org/obo/NCIT_C39747) (Pleomorphic Variant Mantle Cell Lymphoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39743](http://purl.obolibrary.org/obo/NCIT_C39743) (Fascicular Pattern))) 38.69%


